On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.

An opioid epidemic in this society, a pain crisis in others
Non-medical use of prescription opioids is now the fourth most-prevalent form of substance use in Canada; it trails only alcohol, tobacco, and cannabis.
Snapshot of addiction
10 interesting stats on the treatment of drug dependency across Australia, including uptake of opioid pharmacotherapy.
Spectrum: Drugs, addiction and the brain
For the fourth year running, the number of drug-related deaths in Germany has risen.
EMCDDA Update: Drug consumption rooms: an overview of provision and evidence
Supervised drug consumption facilities, have been operating in Europe for the last 30 years. They help to reduce the acute risks of disease transmission, prevent drug-related overdose deaths and connect high-risk people who use drugs with addiction treatment and other health and social services.
'Alarmingly high' risk of death for people with opioid use disorder in general medical care
Almost one-fifth of patients with opioid use disorder (OUD) in a large healthcare system died during a four-year follow-up period, reports a new study.
Why are senior citizens using more illicit drugs?
A perfect storm of alcohol and drugs is brewing for elders.
Thirty years of harm reduction in the Netherlands: HCV elimination in drug users ahead.
This article is based on a presentation given by Esther Croes at the Hepatitis Community Summit 2017 in Amsterdam, on April 19, 2017.
The unsung pillars of HCV elimination - Daniel Simões
The World Health Organization’s Global Strategy and Regional Action Plans for Hepatitis outline an ambitious scenario for 2030: eliminate viral Hepatitis as a public health threat.
Drug related deaths in the U.S.A.
The U.S. government does not track death rates for every drug. However, the National Center for Health Statistics at the Centers for Disease Control and Prevention does collect information on many of the more commonly used drugs.
Hepatitis infection - the end is nigh
Written by IDHDP Director, Graham Foster, Professor of Hepatology Queen Mary University of London. All of the modelling completed to-date suggests that treating those who are actively using drugs will dramatically reduce onward transmission of hepatitis C and many experts see treatment in those with on-going drug use as the key to control of the hepatitis C epidemic.
Share this on: